Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Oral Anamorelin After Total Gastrectomy
jRCTs041230012Phase 2Active, not recruiting
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of anamorelin in post-gastrectomy malnutrition and Loss of appetite. Started Aug 2023; status: active, not recruiting.
02
Drugs
anamorelin
03
Conditions
post-gastrectomy malnutritionLoss of appetite
Beyond the preview
Go deeper on jRCTs041230012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041230012.